- Home
- YFOR vs TVGN Comparison
YFOR vs TVGN Comparison
Compare YFOR & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YFOR | TVGN |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 21.3M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | YFOR | TVGN |
|---|---|---|
| Price | $0.31 | $6.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 368.7K | 3.7K |
| Earning Date | 09-24-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.83 | N/A |
| Revenue Next Year | $31.64 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.29 | $0.14 |
| 52 Week High | $2.05 | $33.20 |
Technical Indicators
Market Signals| Indicator | YFOR | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 25.67 | 48.40 |
| Support Level | N/A | $6.15 |
| Resistance Level | $2.05 | $7.65 |
| Average True Range (ATR) | 0.11 | 0.53 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 1.88 | 62.94 |
Price Performance
Historical ComparisonAbout TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.